Atypical heparin-induced thrombocytopenia complicated by intracardiac thrombus, effectively treated with ultra-low-dose rt-PA lysis and recombinant hirudin (Lepirudin)

Autor: Zinke H, Greinacher A, Motz W, Wacke W, Schwock M, Möx B, Wiersbitzky M, Kraatz G, Eichler P, Olbrich K

Publikováno v: Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 9(3)

A serious retroperitoneal bleeding occurred in a 56-year-old male patient receiving unfractionated heparin due to multiple pulmonary embolism. After reducing the heparin dose, the patient developed a new pulmonary embolism and a large thrombus in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50fb8566d5cad4af189df6c3348a37b8
https://pubmed.ncbi.nlm.nih.gov/9663711

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Atypical heparin-induced thrombocytopenia complicated by intracardiac thrombus, effectively treated with ultra-low-dose rt-PA lysis and recombinant hirudin (Lepirudin).

Autor: Olbrich K; Institute for Immunology and Transfusion Medicine, Ernst-Moritz-Arndt-University Greifswald, Germany., Wiersbitzky M, Wacke W, Eichler P, Zinke H, Schwock M, Möx B, Kraatz G, Motz W, Greinacher A

Publikováno v: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 1998 Apr; Vol. 9 (3), pp. 273-7.

Association between lipid-rich plaques and thrombus formation after excimer laser coronary angioplasty in in-stent restenosis and de novo lesions.

Autor: Nakano T; Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan., Ikenaga H; Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. hirokiikenaga@yahoo.co.jp., Takeda A; Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan., Morita Y; Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan., Higashihara T; Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan., Watanabe N; Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan., Sada Y; Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan., Nakano Y; Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Publikováno v: Lasers in medical science [Lasers Med Sci] 2024 Dec 16; Vol. 39 (1), pp. 295. Date of Electronic Publication: 2024 Dec 16.